NO20043633L - Oral doseringsform for kontrollert medikamentfrigivning - Google Patents

Oral doseringsform for kontrollert medikamentfrigivning

Info

Publication number
NO20043633L
NO20043633L NO20043633A NO20043633A NO20043633L NO 20043633 L NO20043633 L NO 20043633L NO 20043633 A NO20043633 A NO 20043633A NO 20043633 A NO20043633 A NO 20043633A NO 20043633 L NO20043633 L NO 20043633L
Authority
NO
Norway
Prior art keywords
dosage form
oral dosage
drug release
controlled drug
controlled
Prior art date
Application number
NO20043633A
Other languages
English (en)
Other versions
NO334453B1 (no
Inventor
Vincenzo Re
Luigi Martini
Helen Anne Willy
Chi Leung Li
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0203296.9A external-priority patent/GB0203296D0/en
Priority claimed from GB0203297A external-priority patent/GB0203297D0/en
Priority claimed from GB0203298A external-priority patent/GB0203298D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20043633L publication Critical patent/NO20043633L/no
Publication of NO334453B1 publication Critical patent/NO334453B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20043633A 2002-02-12 2004-08-31 Oral doseringsform for kontrollert medikamentfrigivning, fremgangsmåte for fremstilling samt anvendelse derav NO334453B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0203296.9A GB0203296D0 (en) 2002-02-12 2002-02-12 Novel composition
GB0203297A GB0203297D0 (en) 2002-02-12 2002-02-12 Novel composition
GB0203298A GB0203298D0 (en) 2002-02-12 2002-02-12 Novel composition
PCT/GB2003/000594 WO2003068195A1 (en) 2002-02-12 2003-02-12 Oral dosage form for controlled drug release

Publications (2)

Publication Number Publication Date
NO20043633L true NO20043633L (no) 2004-10-27
NO334453B1 NO334453B1 (no) 2014-03-03

Family

ID=27738830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043633A NO334453B1 (no) 2002-02-12 2004-08-31 Oral doseringsform for kontrollert medikamentfrigivning, fremgangsmåte for fremstilling samt anvendelse derav

Country Status (34)

Country Link
EP (1) EP1474114B1 (no)
JP (2) JP2005526031A (no)
KR (2) KR101048925B1 (no)
CN (1) CN100444833C (no)
AP (1) AP1736A (no)
AR (1) AR038417A1 (no)
AT (1) ATE455540T1 (no)
AU (1) AU2003245763B2 (no)
BR (1) BRPI0307319B8 (no)
CA (1) CA2475544A1 (no)
CL (1) CL2007003010A1 (no)
CO (1) CO5601025A2 (no)
CY (1) CY1109939T1 (no)
DE (1) DE60331041D1 (no)
DK (1) DK1474114T3 (no)
EA (1) EA008286B1 (no)
EC (1) ECSP045232A (no)
ES (1) ES2336319T3 (no)
HK (1) HK1072194A1 (no)
IL (1) IL163098A (no)
IS (1) IS2747B (no)
MA (1) MA27689A1 (no)
MX (1) MXPA04007794A (no)
MY (1) MY139719A (no)
NO (1) NO334453B1 (no)
NZ (1) NZ534152A (no)
OA (1) OA12770A (no)
PE (1) PE20030800A1 (no)
PL (1) PL206596B1 (no)
PT (1) PT1474114E (no)
SI (1) SI1474114T1 (no)
TW (1) TWI286079B (no)
UY (1) UY27660A1 (no)
WO (1) WO2003068195A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0120835D0 (en) 2001-08-28 2001-10-17 Smithkline Beecham Plc Process
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
UY28457A1 (es) * 2003-08-07 2005-03-31 Sb Pharmco Inc Nueva composición
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
CN103211779B (zh) * 2006-01-27 2016-03-16 阿代尔制药股份有限公司 包含弱碱性选择性5-羟色胺5-ht3阻断剂和有机酸的药物递送系统
ES2533563T5 (es) * 2006-01-27 2018-07-24 Adare Pharmaceuticals, Inc. Sistemas de suministro de fármacos que comprenden fármacos débilmente básicos y ácidos orgánicos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
DZ2937A1 (fr) * 1998-11-12 2004-03-15 Smithkline Beecham Plc Compositions nouvelles de sensibilidants à l'insuline.
WO2000028989A1 (en) * 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
GB0027471D0 (en) * 2000-11-08 2000-12-27 Smithkline Beecham Plc Processes

Also Published As

Publication number Publication date
BRPI0307319B1 (pt) 2018-05-02
UY27660A1 (es) 2003-09-30
KR101048925B1 (ko) 2011-07-12
TWI286079B (en) 2007-09-01
EP1474114B1 (en) 2010-01-20
JP2010159301A (ja) 2010-07-22
JP5279757B2 (ja) 2013-09-04
CA2475544A1 (en) 2003-08-21
HK1072194A1 (en) 2005-08-19
KR20100086084A (ko) 2010-07-29
BR0307319A (pt) 2005-01-04
PL206596B1 (pl) 2010-08-31
JP2005526031A (ja) 2005-09-02
AR038417A1 (es) 2005-01-12
MXPA04007794A (es) 2004-10-15
CL2007003010A1 (es) 2008-01-25
TW200307567A (en) 2003-12-16
MY139719A (en) 2009-10-30
DE60331041D1 (de) 2010-03-11
EP1474114A1 (en) 2004-11-10
EA200401071A1 (ru) 2004-12-30
SI1474114T1 (sl) 2010-04-30
AU2003245763A1 (en) 2003-09-04
IS2747B (is) 2011-08-15
ES2336319T3 (es) 2010-04-12
NO334453B1 (no) 2014-03-03
PL371368A1 (en) 2005-06-13
NZ534152A (en) 2006-11-30
AP2004003087A0 (en) 2004-09-30
AP1736A (en) 2007-05-02
ATE455540T1 (de) 2010-02-15
CO5601025A2 (es) 2006-01-31
WO2003068195A1 (en) 2003-08-21
AU2003245763B2 (en) 2008-12-11
OA12770A (en) 2006-07-04
CN1655768A (zh) 2005-08-17
IS7383A (is) 2004-08-05
KR20040084900A (ko) 2004-10-06
ECSP045232A (es) 2004-09-28
IL163098A (en) 2009-05-04
BRPI0307319B8 (pt) 2021-05-25
DK1474114T3 (da) 2010-04-12
EA008286B1 (ru) 2007-04-27
PE20030800A1 (es) 2003-10-31
PT1474114E (pt) 2010-03-04
MA27689A1 (fr) 2006-01-02
CY1109939T1 (el) 2014-09-10
CN100444833C (zh) 2008-12-24

Similar Documents

Publication Publication Date Title
HK1085131A1 (en) Solid drug for oral use
EP1553925A4 (en) ORAL DOSAGE FORM WITH MODIFIED RELEASE
PT1501534E (pt) Formulacoes farmaceuticas
CY2018005I1 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
DE60308372D1 (de) Dosierungsverabreichungsvorrichtung
CY2007031I1 (el) Συνθεση στοματικης δοσολογιας παρατεταμενης απελευθερωσης
ZA200605631B (en) Directly compressible pharmaceutical composition for the oral administration of CCI-779
ATE372765T1 (de) Feste pharmazeutische formulierungen mit telmisartan
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
IS7481A (is) Epóthílon til gjafar um munn
HK1072194A1 (en) Oral dosage form for controlled drug release
NO20041383L (no) Flashsmelte oral doseringsformulering
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
ATE551051T1 (de) Orales arzneimittelabgabesystem
ATE327759T1 (de) Pharmazeutische zusammensetzung mit verlungerter freisetzung
NO20044188L (no) Kontrollerte frigjoringsdoseformer
DE60336999D1 (de) Melatonin enthaltende pharmazeutische formulierung
AU2003261067A8 (en) Modified release ketoprofen dosage form
NO20043007L (no) Farmasoytisk suspensjon for oral administrering
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
ITTO20020672A0 (it) Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
GB0322848D0 (en) Tetracycline controlled release pharmaceutical dosage form
ITMI20020921A0 (it) Dispositivo per la sommistrazione di farmaci
PL373776A1 (en) Oral pharmaceutical compound
NO20025959D0 (no) Dispenser for tanntråd

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: GLAXO GROUP LTD, GB

MK1K Patent expired